Chapter 1: Overview of Real-World Data


  1. U.S. Food and Drug Administration. Framework for FDA’s Real-World Evidence Program. Published online January 4, 2022. Accessed January 4, 2022.
  2. U.S. Food and Drug Administration. Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products. Published October 27, 2021. Accessed November 30, 2021.…
  3. Curtis LH, Weiner MG, Boudreau DM, et al. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf. 2012;21 Suppl 1:23-31. doi:10.1002/pds.2336
  4. Richard Platt, Pamela Tenaerts, Patrick Archdeacon, et al. Developing Approaches to Conducting Randomized Trials Using the Mini-Sentinel Distributed Database. Published online February 28, 2014. Accessed February 17, 2017.…
  5. Platt R, Brown JS, Robb M, et al. The FDA Sentinel Initiative — An Evolving National Resource. N Engl J Med. 2018;379(22):2091-2093. doi:10.1056/NEJMp1809643
  6. Qualls LG, Phillips TA, Hammill BG, et al. Evaluating Foundational Data Quality in the National Patient-Centered Clinical Research Network (PCORnet®). eGEMs. 2018;6(1):3. doi:10.5334/egems.199
  7. Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. Journal of the American Medical Informatics Association. 2014;21(4):578-582. doi:10.1136/amiajnl-2014-002747
  8. Califf RM. The Patient-Centered Outcomes Research Network: a national infrastructure for comparative effectiveness research. N C Med J. 2014;75(3):204-210. doi:10.18043/ncm.75.3.204
  9. May T. How America’s Health Data Infrastructure is Being Used to Fight COVID-19. Datavant. Accessed January 4, 2022.…
  10. Miksad RA, Abernethy AP. Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality. Clin Pharmacol Ther. 2018;103(2):202-205. doi:10.1002/cpt.946
  11. Marsolo K, Richesson R, Hammond WE. Rethinking Clinical Trials. Acquiring Real-Word Data. NIH Health Care Systems Research Collaboratory…
  12. Tang PC, Ash JS, Bates DW, Overhage JM, Sands DZ. Personal Health Records: Definitions, Benefits, and Strategies for Overcoming Barriers to Adoption. Journal of the American Medical Informatics Association. 2006;13(2):121-126. doi:10.1197/jamia.M2025
  13. U.S. Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures:  Use in Medical Product Development  to Support Labeling Claims. Published online December 2009. Accessed September 25, 2013.
  14. Chen M, Tan X, Padman R. Social determinants of health in electronic health records and their impact on analysis and risk prediction: A systematic review. Journal of the American Medical Informatics Association. 2020;27(11):1764-1773. doi:10.1093/jamia/ocaa143
  15. Eisenstein EL, Curtis LH, Prather K, et al. Using Death as an Endpoint. In: The Living Textbook. NIH Collaboratory; 2017. doi:10.28929/118
  16. Pratt NL, Mack CD, Meyer AM, et al. Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting. Pharmacoepidemiol Drug Saf. 2020;29(1):9-17. doi:10.1002/pds.4924
  17. Rivera DR, Gokhale MN, Reynolds MW, et al. Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility. Pharmacoepidemiol Drug Saf. 2020;29(1):18-29. doi:10.1002/pds.4918
  18. Daniel G, Silcox C, Bryan J. Characterizing RWD Quality and Relevancy for Regulatory Purposes. Accessed January 4, 2022.
  19. Gatto NM, Campbell UB, Rubinstein E, et al. The Structured Process to Identify Fit‐For‐Purpose Data: A Data Feasibility Assessment Framework. Clin Pharma and Therapeutics. 2022;111(1):122-134. doi:10.1002/cpt.2466
  20. Federal Information Security Modernization Act | CISA. Accessed January 27, 2022.
  21. Nifakos S, Chandramouli K, Nikolaou CK, et al. Influence of Human Factors on Cyber Security within Healthcare Organisations: A Systematic Review. Sensors. 2021;21(15):5119. doi:10.3390/s21155119